QUANTUM X LABS INC. quarterly report, Q3 FY2011

Business context and reporting period

This Form 10-Q covers the quarter and nine months ended September 30, 2011. The filing identifies the registrant as Zaxis International Inc., not Quantum X Labs Inc. Zaxis reports that it ceased its former biotechnology operations in 2002, has no present operations, and is seeking a business combination. It checked the box indicating it is a shell company. No target business or industry has been selected.

Financial condition and results

MetricThree months ended September 30Nine months ended September 30
Revenue$0 in 2011 and 2010$0 in 2011 and 2010
General and administrative expense$9,500 in 2011; $9,500 in 2010$30,930 in 2011; $30,729 in 2010
Interest expense$1,750 in 2011; $1,050 in 2010$3,850 in 2011; $3,150 in 2010
Net loss$11,250 in 2011; $10,550 in 2010$34,780 in 2011; $33,879 in 2010
Basic and diluted loss per share$(0.01) in both periods$(0.02) in both periods

With no revenue, the company has no meaningful operating margin to report. At September 30, 2011, cash and total assets were $0. Reported total liabilities were $143,849, comprising $108,849 of current liabilities and $35,000 of noncurrent related-party convertible notes. Stockholders’ deficiency was $143,849. At December 31, 2010, total liabilities were $164,629 and stockholders’ deficiency was $164,629.

Cash flows from operating, investing, and financing activities were each reported as $0 for the first nine months of 2011 and 2010; ending cash was $0 in both periods. The 2011 cash-flow reconciliation includes $27,000 of related-party services and $7,780 of increases in accounts payable and accrued expenses, indicating that reported expenses were substantially supported through noncash services and accruals rather than cash spending.

Changes versus the prior comparable periods

  • Nine-month net loss increased by $901, to $34,780, versus $33,879 in 2010; quarterly net loss increased by $700.
  • Nine-month general and administrative expense rose by $201, while interest expense rose by $700.
  • Common shares outstanding increased from 1,495,126 at December 31, 2010 to 1,695,126 at September 30, 2011. The filing does not clearly explain the share issuance or its consideration in the presented financial statements.
  • Accumulated deficit increased from $251,264 to $286,044. The balance sheet reports current liabilities increasing from $79,629 to $108,849, while total liabilities decreased to $143,849.

Outlook, risks, and unusual items

Management plans to use limited resources to pursue an acquisition or merger but has no identified target and gives no transaction timetable or financial forecast. Management says a business combination may require issuing substantial restricted shares, potentially diluting existing holders and changing control. The company has no agreements to raise debt or equity, and says financing may not be available on acceptable terms.

The financial statements disclose accumulated losses of $286,044 and insufficient working capital to meet operating needs for the next twelve months, raising substantial doubt about the company’s ability to continue as a going concern. The filing also warns that a business combination could involve an early-stage or financially unstable company, and that the company may be dependent on a single business after a transaction.

Related-party arrangements are significant. The CEO provided services valued at $2,000 per month, and an affiliated entity provided office space valued at $1,000 per month; the filing records $27,000 in total for the first nine months of 2011. A $35,000 convertible note to the president bears 12% interest, is due December 31, 2012, and converts initially at $0.10 per share. A further $50,000 note issued to the president on August 1, 2011 bears 12% interest, is due December 31, 2013, and converts initially at $0.03 per share. The filing says the notes formalize prior cash advances and services and that the conversion and liquidated-damages provisions were not treated as derivatives.

Management concluded that disclosure controls were effective as of September 30, 2011 and reported no material change in internal control over financial reporting. The filing reports no legal proceedings and no market-risk hedging or trading activity.

Important facts for investors to verify

  • Confirm the identity of the issuer: the supplied filing is for Zaxis International Inc., although the request metadata names Quantum X Labs Inc.
  • Reconcile the related-party note balances. The balance sheet lists $35,000 of noncurrent convertible notes at September 30, 2011, although the notes describe a $35,000 note and a subsequent $50,000 note issuance.
  • Reconcile the related-party accrual disclosures: the balance sheet reports $103,599 of advances and accruals due to related parties at September 30, 2011, while Note 4 states that amounts due totaled $70,029 at that date.
  • Clarify the increase of 200,000 common shares, the consideration received, and the effect on ownership; the filing separately states that management owns 82% of outstanding shares.
  • Assess the company’s ability to fund operations and complete a business combination given zero cash and assets, no current operations, and management’s going-concern warning.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.